These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12425485)

  • 21. Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.
    Akman B; Uyar M; Afsar B; Sezer S; Ozdemir FN; Haberal M
    Transplant Proc; 2007; 39(1):135-7. PubMed ID: 17275490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of AUC(0-4) predictive methods for cyclosporine in kidney transplant patients].
    Aoyama T; Matsumoto Y; Shimizu M; Fukuoka M; Kimura T; Kokubun H; Yoshida K; Yago K
    Yakugaku Zasshi; 2005 May; 125(5):441-7. PubMed ID: 15863976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
    Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
    Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered flow properties of blood and increased plasma fibrinogen in cyclosporin-treated renal allograft recipients.
    Linde T; Sandhagen B; Backman U; Fellström B
    Nephrol Dial Transplant; 1999 Jun; 14(6):1525-9. PubMed ID: 10383019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
    Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interstitial Lung Disease After Kidney Transplantation and the Role of Everolimus.
    Solazzo A; Botta C; Nava F; Baisi A; Bonucchi D; Cappelli G
    Transplant Proc; 2016 Mar; 48(2):349-51. PubMed ID: 27109953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac and vascular abnormalities in renal transplant patients: differential effects of cyclosporin and azathioprine.
    Galiatsou E; Morris ST; Jardine AG; Rodger RS; Watson MA; Elliott HL
    J Nephrol; 2000; 13(3):185-92. PubMed ID: 10928294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients.
    Ferraresso M; Citterio F; Ghio L; Romagnoli J; Edefonti A; Berardinelli L; Castagneto M
    Transplant Proc; 2004 Nov; 36(9):2656-8. PubMed ID: 15621115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal cyclosporine therapy--an Indian experience.
    Raj DS; Somiah S; Mani K
    J Assoc Physicians India; 1996 Jan; 44(1):34-6. PubMed ID: 8773092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equivalence of cyclosporine blood level assays in patients receiving cyclosporine microemulsion or cyclosporine. The Sandoz Neoral Study Group N103.
    Pescovitz MD; Wong RL; Choc MG; Chang CT
    Clin Transplant; 1997 Oct; 11(5 Pt 1):442-5. PubMed ID: 9361938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incidence of gout in renal transplant recipients.
    West C; Carpenter BJ; Hakala TR
    Am J Kidney Dis; 1987 Nov; 10(5):369-72. PubMed ID: 3314490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients.
    Strózecki P; Adamowicz A; Włodarczyk Z; Manitius J
    Ren Fail; 2007; 29(6):679-84. PubMed ID: 17763162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advantages of Neoral conversion in renal transplant patients.
    Vennarecci G; Pisani F; Tisone G; Buonomo O; Famulari A; Casciani CU
    Minerva Urol Nefrol; 1998 Jun; 50(2):161-4. PubMed ID: 9707972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary experience with mycophenolate mofetil for preservation of renal function in cardiac transplant patients with documented cyclosporine nephrotoxicity.
    Al-Aly Z; Sachdeva A; Philoctete Ashley JM; Bastani B
    Nephrology (Carlton); 2006 Apr; 11(2):151-5. PubMed ID: 16669979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ketoconazole on cyclosporine dose in healthy dogs.
    Dahlinger J; Gregory C; Bea J
    Vet Surg; 1998; 27(1):64-8. PubMed ID: 9449179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impairment of tubular secretion of urate in renal transplant patients on cyclosporine.
    Marcén R; Gallego N; Orofino L; Gámez C; Estepa MR; Sabater J; Teruel JL; Ortuño J
    Nephron; 1995; 70(3):307-13. PubMed ID: 7477618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporin A has no impact on alterations of the lipid profile after renal transplantation.
    Rosman J; Evequoz D; Landmann J; Thiel G
    Transpl Int; 1992; 5 Suppl 1():S532-5. PubMed ID: 14621868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients.
    Cauduro RL; Costa C; Lhulier F; Garcia RG; Cabral RD; Gonçalves LF; Manfro RC
    Clin Transplant; 2005 Aug; 19(4):470-4. PubMed ID: 16008590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.